High-Mobility Group Box 1 Protein in CSF of Patients with Subarachnoid Hemorrhage

Overview of attention for article published in Neurocritical Care, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Purification and purity assessment of RNA molecules synthesized with modified nucleosides

Grant US-11060107-B2

United States of America

HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders

Grant US-9766254-B2

United States of America

HMGB1 AND ANTI-HMGB1 ANTIBODY FOR PROGNOSIS OF NEUROLOGICAL DISORDER

Application JP-2016029397-A

Japan

HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders

Grant US-9164107-B2

United States of America

HMGB1 and anti-HMGB1 antibodies for the prognosis of neurological disorders

Application EP-2720043-A3

European Patent Office

HMGB1 AND ANTI-HMGB1 ANTIBODIES FOR THE PROGNOSTIC OF NEUROLOGICAL DISORDERS

Application WO-2011110650-A3

World Intellectual Property Organisation (WIPO)